Literature DB >> 15017622

Assessing quality of life in primary biliary cirrhosis.

Anne Rannard1, Deborah Buck, David E J Jones, Oliver F W James, Ann Jacoby.   

Abstract

BACKGROUND AND AIMS: Assessment of health-related quality of life (HRQOL) is not routinely reported in the literature on chronic liver disease (CLD). Few studies have examined quality of life (QOL) in patients with primary biliary cirrhosis (PBC) despite its significant functional impact. One of the reasons for the lack of HRQOL measurement in patients with PBC may be the absence of a well-recognized and widely used measure that clinicians can use in ordinary clinical practice. The aim of this study is to evaluate HRQOL measures used in patients with PBC and examine the suitability of the measures for these patients.
METHODS: A literature search identified reports that focused on any aspect of QOL in patients with PBC. Key texts were identified containing generic, domain-specific, and condition-specific measures. The identified measures were systematically evaluated for appropriateness, acceptability, reliability, validity, precision, and responsiveness.
RESULTS: Twenty measures were identified from 9 key texts. Six of the measures were previously validated generic measures; 10 were domain-specific measures previously used to measure fatigue, depression, and psychological distress in general and psychiatric populations; and 4 measures had been developed in patients with CLD. Reporting of reliability and validity generally was consistent for all measures used. However, reporting of the remaining criteria was variable, particularly in relation to responsiveness over time and acceptability of the measures to patients with PBC.
CONCLUSIONS: A clearer and more rigorous approach is needed in reporting the properties of HRQOL measures used in patients with PBC to help clinicians decide which measures are most suitable for these patients.

Entities:  

Mesh:

Year:  2004        PMID: 15017622     DOI: 10.1016/s1542-3565(03)00323-9

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  9 in total

1.  Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis.

Authors:  A Jacoby; A Rannard; D Buck; N Bhala; J L Newton; O F W James; D E J Jones
Journal:  Gut       Date:  2005-06-16       Impact factor: 23.059

Review 2.  Evaluation of the methodological quality of systematic reviews of health status measurement instruments.

Authors:  Lidwine B Mokkink; Caroline B Terwee; Paul W Stratford; Jordi Alonso; Donald L Patrick; Ingrid Riphagen; Dirk L Knol; Lex M Bouter; Henrica C W de Vet
Journal:  Qual Life Res       Date:  2009-02-24       Impact factor: 4.147

3.  Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort.

Authors:  D E J Jones; N Bhala; J Burt; J Goldblatt; M Prince; J L Newton
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

4.  Fluoxetine for the treatment of fatigue in primary biliary cirrhosis: a randomized, double-blind controlled trial.

Authors:  Jayant A Talwalkar; Jessica J Donlinger; Andrea A Gossard; Jill C Keach; Roberta A Jorgensen; Janice C Petz; Keith D Lindor
Journal:  Dig Dis Sci       Date:  2006-10-20       Impact factor: 3.199

5.  Moexipril for treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.

Authors:  Phunchai Charatcharoenwitthaya; Jayant A Talwalkar; Paul Angulo; Andrea A Gossard; Jill C Keach; Janice L Petz; Roberta A Jorgensen; Keith D Lindor
Journal:  Dig Dis Sci       Date:  2009-03-03       Impact factor: 3.199

6.  Reduced brain content of arachidonic acid and docosahexaenoic acid is related to the severity of liver fibrosis.

Authors:  Chih-Cheng Chen; Li-Tung Huang; You-Lin Tain; Hsio-Chi Chaung; Chih-Sung Hsieh; Hock-Liew Eng; Yu-Ching Wei; Chun-Yu Yang
Journal:  Dig Dis Sci       Date:  2010-01-26       Impact factor: 3.199

7.  Health-related quality of life in chinese patients with chronic liver disease.

Authors:  Ru Gao; Feng Gao; Guang Li; Jian Yu Hao
Journal:  Gastroenterol Res Pract       Date:  2012-06-03       Impact factor: 2.260

8.  Health-related quality of life and survival in Chinese patients with chronic liver disease.

Authors:  Feng Gao; Ru Gao; Guang Li; Zhan Min Shang; Jian Yu Hao
Journal:  Health Qual Life Outcomes       Date:  2013-08-01       Impact factor: 3.186

9.  Translation and validation of the Serbian primary biliary cholangitis-40 questionnaire.

Authors:  Simon Zec; Dusan Popovic; Vera Matovic; Vladimir Nikolic; Ksenija Bojovic; Jasna Jovic; Ljiljana Markovic Denic; Tomica Milosavljevic; Tamara Alempijevic
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.